Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,340
+150 (1.34%)
At close: Jul 18, 2025, 3:30 PM KST
1.34%
Market Cap225.03B
Revenue (ttm)217.69B
Net Income (ttm)-12.97B
Shares Out21.23M
EPS (ttm)-661.88
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume603,860
Average Volume192,347
Open12,300
Previous Close11,190
Day's Range11,150 - 12,300
52-Week Range8,150 - 19,500
Beta0.35
RSI49.48
Earnings DateAug 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.